Relish Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on February 12, 2016, to consider, adopt and approve Un-audited Financial Results for the quarter ended on December 31, 2015. Further, the Trading Window of the Company will remain closed from February 10, 2016 to February 14, 2016.
The above information is a part of company’s filings submitted to BSE.